Aim: The study was conducted to evaluate the effect of Ginkgo biloba on serum uric acid level when used as add-on therapy to valsartan in hypertensive patients.

Patients and Methods:

The study was conducted in Private Clinics in Mosul City-Iraq, during a period of sixth months from 15 October 2017 to15 April 2018. The total number of patients  enrolled in the study was 50 hypertensive patients  using Valsartan mono-therapy of both sexes. The patients were administered Ginkgo biloba 80 mg twice daily and followed for 2 months duration. Their serum uric acid level was determined at baseline level and after 2 months from administration of Ginkgo biloba.

Results: There was a significant reduction on serum uric acid level after two months from addition of Ginkgo biloba.

Conclusions: This study revealed that Ginkgo biloba could be regarded as natural and relatively safe drug in reducing serum uric acid level.